245
Views
17
CrossRef citations to date
0
Altmetric
Original Research

Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies

, , , , , , , , , , , , , , & show all
Pages 571-583 | Published online: 18 Jul 2013

References

  • Hinoda Y [Molecular targeted cancer therapy and genetic tests – chairman’s introductory remarks.] Rinsho Byori 2012 60 10 967 968 Japanese 23323461
  • Domvri K Darwiche K Zarogoulidis P Zarogoulidis K Following the crumbs: from tissue samples, to pharmacogenomics, to NSCLC therapy Transl Lung Cancer Res 2012 10.3978/j.issn.2218-6751.2012.12.06
  • Saijo N The role of pharmacoethnicity in the development of cytotoxic and molecular targeted drugs in oncology Yonsei Med J 2013 54 1 1 14 23225792
  • Savonarola A Palmirotta R Guadagni F Silvestris F Pharmacogenetics and pharmacogenomics: role of mutational analysis in anti-cancer targeted therapy Pharmacogenomics J 2012 12 4 277 286 22760589
  • Mamot C Drummond DC Noble CO Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo Cancer Res 2005 65 24 11631 11638 16357174
  • Giovannetti E Toffalorio F De Pas T Peters GJ Pharmacogenetics of conventional chemotherapy in non-small-cell lung cancer: a changing landscape? Pharmacogenomics 2012 13 9 1073 1086 22838953
  • Yin JY Huang Q Zhao YC Zhou HH Liu ZQ Meta-analysis on pharmacogenetics of platinum-based chemotherapy in non small cell lung cancer (NSCLC) patients PLoS One 2012 7 6 e38150 22761669
  • Mayo C Bertran-Alamillo J Molina-Vila MA Gimenez-Capitan A Costa C Rosell R Pharmacogenetics of EGFR in lung cancer: perspectives and clinical applications Pharmacogenomics 2012 13 7 789 802 22594511
  • Wang S Peng L Li J A trial-based cost-effectiveness analysis of erlotinib alone versus platinum-based doublet chemotherapy as first-line therapy for eastern asian nonsquamous non-small-cell lung cancer PLoS One 2013 8 3 e55917 23520448
  • Ihbe-Heffinger A Paessens B Berger K The impact of chemotherapy-induced side effects on medical care usage and cost in German hospital care – an observational analysis on non-small-cell lung cancer patients Support Care Cancer 2013 21 6 1665 1675 23338228
  • Mylonaki E Manika K Zarogoulidis P In vivo synergistic cytogenetic effects of aminophylline on lymphocyte cultures from patients with lung cancer undergoing chemotherapy Mutat Res 2012 740 1–2 1 5 23116732
  • Boutsikou E Kontakiotis T Zarogoulidis P Docetaxel-carboplatin in combination with erlotinib and/or bevacizumab in patients with non-small cell lung cancer Onco Targets Ther 2013 6 125 134 23467839
  • Zarogoulidis K Eleftheriadou E Kontakiotis T Long acting somatostatin analogues in combination to antineoplastic agents in the treatment of small cell lung cancer patients Lung Cancer 2012 76 1 84 88 22018594
  • Zarogoulidis K Ziogas E Papagiannis A Interferon alpha-2a and combined chemotherapy as first line treatment in SCLC patients: a randomized trial Lung Cancer 1996 15 2 197 205 8882986
  • Hohenforst-Schmidt W Intratumoral Chemotherapy (ITC) – a forgotten option at least in functionally or oncologically driven palliation! Paper presented at: 16th WCBE 20102010
  • Celikoglu F Celikoglu SI Goldberg EP Bronchoscopic intratumoral chemotherapy of lung cancer Lung Cancer 2008 61 1 1 12 18455832
  • Kar UK Srivastava MK Andersson A Novel CCL21-vault nanocapsule intratumoral delivery inhibits lung cancer growth PLoS One 2011 6 5 e18758 21559281
  • Macha HN Freitag L The role of brachytherapy in the treatment and control of central bronchial carcinoma Monaldi Arch Chest Dis 1996 51 4 325 328 8909019
  • Freitag L Ernst A Thomas M Prenzel R Wahlers B Macha HN Sequential photodynamic therapy (PDT) and high dose brachytherapy for endobronchial tumour control in patients with limited bronchogenic carcinoma Thorax 2004 59 9 790 793 15333857
  • Porpodis K Karanikas M Zarogoulidis P A case of typical pulmonary carcinoid tumor treated with bronchoscopic therapy followed by lobectomy J Multidiscip Healthc 2012 5 47 51 22396625
  • Freitag L Macha H-N Loddenkemper R Interventional bronchoscopic procedures Eur Resp mon 2001 17 272 304
  • Zarogoulidis P Chatzaki E Porpodis K Inhaled chemotherapy in lung cancer: future concept of nanomedicine Int J Nanomedicine 2012 7 1551 1572 22619512
  • Zarogoulidis P Eleftheriadou E Sapardanis I Feasibility and effectiveness of inhaled carboplatin in NSCLC patients Invest New Drugs 2012 30 4 1628 1640 21739158
  • Darwiche K Zarogoulidis P Karamanos NK Efficacy versus safety concerns for aerosol chemotherapy in non-small-cell lung cancer: a future dilemma for micro-oncology Future Oncol 2013 9 4 505 525 23560374
  • Fujiwara T Tanaka N Kanazawa S Multicenter phase I study of repeated intratumoral delivery of adenoviral p53 in patients with advanced non-small-cell lung cancer J Clin Oncol 2006 24 11 1689 1699 16505415
  • Zarogoulidis P Chatzaki E Hohenforst-Schmidt W Management of malignant pleural effusion by suicide gene therapy in advanced stage lung cancer: a case series and literature review Cancer Gene Ther 2012 19 9 593 600 22744209
  • Jia Y Yuan M Yuan H Co-encapsulation of magnetic Fe3O4 nanoparticles and doxorubicin into biodegradable PLGA nanocarriers for intratumoral drug delivery Int J Nanomedicine 2012 7 1697 1708 22619520
  • Cunha-Filho MS Alvarez-Lorenzo C Martinez-Pacheco R Landin M Temperature-sensitive gels for intratumoral delivery of beta- lapachone: effect of cyclodextrins and ethanol ScientificWorldJournal 2012 2012 126723 22629119
  • Ahmed M Moussa M Goldberg SN Synergy in cancer treatment between liposomal chemotherapeutics and thermal ablation Chem Phys Lipids 2012 165 4 424 437 22197685
  • Horev-Drori G Cooks T Bittan H Local control of experimental malignant pancreatic tumors by treatment with a combination of chemotherapy and intratumoral 224 radium-loaded wires releasing alpha-emitting atoms Transl Res 2012 159 1 32 41 22153808
  • Ginsberg RJ Resection of non-small cell lung cancer: how much and by what route Chest 1997 112 Suppl 4 203S 205S 9337289
  • McGinn CJ Shewach DS Lawrence TS Radiosensitizing nucleosides J Natl Cancer Inst 1996 88 17 1193 1203 8780628
  • Pauwels B Korst AE Lardon F Vermorken JB Combined modality therapy of gemcitabine and radiation Oncologist 2005 10 1 34 51 15632251
  • Shewach DS Lawrence TS Antimetabolite radiosensitizers J Clin Oncol 2007 25 26 4043 4050 17827452
  • Arazi L Cooks T Schmidt M Keisari Y Kelson I Treatment of solid tumors by interstitial release of recoiling short-lived alpha emitters Phys Med Biol 2007 52 16 5025 5042 17671351
  • Celikoglu F Celikoglu SI Intratumoural chemotherapy with 5-fluorouracil for palliation of bronchial cancer in patients with severe airway obstruction J Pharm Pharmacol 2003 55 10 1441 1448 14607028
  • Hohenforst-Schmidt W Intratumoral chemotherapy (ITC) as adjunct therapy in NSCLC iiia–iv prolongs life Poster presented at: International Conference and Exhibition on Cancer Science and Therapy August 15–17, 2011 Las Vegas, NV
  • Bae YH Interview with Dr You Han Bae: ligand-mediated versus ‘passive’ targeting approaches in nanoparticle oncology research Ther Deliv 2012 3 8 933 936 22946427
  • Yang W Ahmed M Elian M Do liposomal apoptotic enhancers increase tumor coagulation and end-point survival in percutaneous radiofrequency ablation of tumors in a rat tumor model? Radiology 2010 257 3 685 696 20858851
  • Le Pivert PJ Morrison DR Haddad RS Percutaneous tumor ablation: microencapsulated echo-guided interstitial chemotherapy combined with cryosurgery increases necrosis in prostate cancer Technol Cancer Res Treat 2009 8 3 207 216 19445538
  • Lin X Gao R Zhang Y Lipid nanoparticles for chemotherapeutic applications: strategies to improve anticancer efficacy Expert Opin Drug Deliv 2012 9 7 767 781 22554018
  • Xie H Goins B Bao A Wang ZJ Phillips WT Effect of intratumoral administration on biodistribution of 64Cu-labeled nanoshells Int J Nanomedicine 2012 7 2227 2238 22619558
  • Sim H Bibee K Wickline S Sept D Pharmacokinetic modeling of tumor bioluminescence implicates efflux, and not influx, as the bigger hurdle in cancer drug therapy Cancer Res 2011 71 3 686 692 21123454
  • Zhao W Zhuang S Qi XR Comparative study of the in vitro and in vivo characteristics of cationic and neutral liposomes Int J Nanomedicine 2011 6 3087 3098 22163162
  • Fang J Qin H Nakamura H Tsukigawa K Shin T Maeda H Carbon monoxide, generated by heme oxygenase-1, mediates the enhanced permeability and retention effect in solid tumors Cancer Sci 2012 103 3 535 541 22145952
  • Celikoglu F Celikoglu SI York AM Goldberg EP Intratumoral administration of cisplatin through a bronchoscope followed by irradiation for treatment of inoperable non-small cell obstructive lung cancer Lung Cancer 2006 51 2 225 236 16359751
  • Celikoglu F Celikoglu SI Goldberg EP Intratumoural chemotherapy of lung cancer for diagnosis and treatment of draining lymph node metastasis J Pharm Pharmacol 2010 62 3 287 295 20487210
  • Celikoglu SI Karayel T Demirci S Celikoglu F Cagatay T Direct injection of anti-cancer drugs into endobronchial tumours for palliation of major airway obstruction Postgrad Med J 1997 73 857 159 162 9135832
  • Horng G Askari S Choi Y Grundfest W Sustained Localized Drug Delivery In Mammalian Lung By Bronchoscopy Paper presented at: American Thoracic Society 2012 International Conference May 18–23, 2012 San Francisco, CA
  • Yeh CT Chen HC Sung CM Retrospective comparison between a regular and a split-dose protocol of 5-fluorouracil, cisplatin, and mitoxantrone for the treatment of far advanced hepatocellular carcinoma BMC Cancer 2011 11 117 21453495
  • Goldberg EP Hadba AR Almond BA Marotta JS Intratumoral cancer chemotherapy and immunotherapy: opportunities for nonsystemic preoperative drug delivery J Pharm Pharmacol 2002 54 2 159 180 11848280
  • Vogl TJ Wissniowski TT Naguib NN Activation of tumor-specific T lymphocytes after laser-induced thermotherapy in patients with colorectal liver metastases Cancer Immunol Immunother 2009 58 10 1557 1563 19184001
  • Monga SP Wadleigh R Sharma A Intratumoral therapy of cisplatin/epinephrine injectable gel for palliation in patients with obstructive esophageal cancer Am J Clin Oncol 2000 23 4 386 392 10955870
  • Wagai F, Kinoshita M, Shiraki R, Watanabe H, Kitamura S. [The direct injection of several anti-cancer drugs into the primary lung cancer lesion through a fiberoptic bronchoscope (author’s transl).] Nihon Kyobu Shikkan Gakkai Zasshi 1982 20 2 170 175 Japanese 7098181
  • Liu M Ma P Lu Z [Local chemotherapy by fibrobronchoscopy for advanced bronchogenic carcinoma.] Zhonghua Jie He He Hu Xi Za Zhi 2000 23 9 550 551 Chinese 11778530
  • Celikoglu SI Celikoglu F Goldberg EP Endobronchial intratumoral chemotherapy (EITC) followed by surgery in early non-small cell lung cancer with polypoid growth causing erroneous impression of advanced disease Lung Cancer 2006 54 3 339 346 17045361
  • Nader AD Intratumoral chemotherapy as an adjuvant to endobronchial brachytherapy Chest 2007 132 Suppl 459
  • Jabbardarjani H Safara H Kharabian S Reza M Endobronchial chemotherapy in malignant airway lesions of the lung: Report of 3 years experience J Bronchology 2007 14 242 245
  • Ramos HC Ruivo I deBrito U Use of intratumoral cisplatinium in lung cancer Experimental Pathology and Healt Science 2008 2 2 45 46
  • He J Ying W Yang H Gemcitabine plus cisplatin chemotherapy with concurrent para-toluenesulfonamide local injection therapy for peripherally advanced nonsmall cell lung cancer larger than 3 cm in the greatest dimension Anticancer Drugs 2009 20 9 838 844 19668080
  • Brincker H Direct intratumoral chemotherapy Crit Rev Oncol Hematol 1993 15 2 91 98 8117417
  • Li C Wang Y Zhang X Deng L Zhang Y Chen Z Tumor-targeted liposomal drug delivery mediated by a diseleno bond-stabilized cyclic peptide Int J Nanomedicine 2013 8 1051 1062 23515368
  • Kosacka M Piesiak P Kowal A Golecki M Jankowska R Galectin-3 and cyclin D1 expression in non-small cell lung cancer J Exp Clin Cancer Res 2011 30 101 22024187
  • Peiris PM Bauer L Toy R Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release ACS Nano 2012 6 5 4157 4168 22486623
  • Werner JA Kehrl W Pluzanska A A phase III placebo-controlled study in advanced head and neck cancer using intratumoural cisplatin/epinephrine gel Br J Cancer 2002 87 9 938 944 12434280
  • Callahan DJ Liu W Li X Triple stimulus-responsive polypeptide nanoparticles that enhance intratumoral spatial distribution Nano Lett 2012 12 4 2165 2170 22417133
  • Govindarajan S Sivakumar J Garimidi P Targeting human epidermal growth factor receptor 2 by a cell-penetrating peptide-affibody bioconjugate Biomaterials 2012 33 8 2570 2582 22192536
  • Gopal V Guruprasad K Structure prediction and validation of an affibody engineered for cell-specific nucleic acid targeting Syst Synth Biol 2010 4 4 293 297 22132056
  • Liu Q Li R Zhu Z Enhanced antitumor efficacy, biodistribution and penetration of docetaxel-loaded biodegradable nanoparticles Int J Pharm 2012 430 1–2 350 358 22525076
  • Watson KD Lai CY Qin S Ultrasound increases nanoparticle delivery by reducing intratumoral pressure and increasing transport in epithelial and epithelial-mesenchymal transition tumors Cancer Res 2012 72 6 1485 1493 22282664
  • Hecht JR Farrell JJ Senzer N EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II study Gastrointest Endosc 2012 75 2 332 338 22248601
  • Hanna N Ohana P Konikoff FM Phase 1/2a, dose-escalation, safety, pharmacokinetic and preliminary efficacy study of intratumoral administration of BC-819 in patients with unresectable pancreatic cancer Cancer Gene Ther 2012 19 6 374 381 22498722
  • Geletneky K Huesing J Rommelaere J Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol BMC Cancer 2012 12 99 22436661
  • Zheng X Zhou F Wu B Chen WR Xing D Enhanced tumor treatment using biofunctional indocyanine green-containing nanostructure by intratumoral or intravenous injection Mol Pharm 2012 9 3 514 522 22332810
  • Luo X Xie C Wang H Liu C Yan S Li X Antitumor activities of emulsion electrospun fibers with core loading of hydroxycamptothecin via intratumoral implantation Int J Pharm 2012 425 1–2 19 28 22265915
  • Luo X Xu G Song H Promoted antitumor activities of acid-labile electrospun fibers loaded with hydroxycamptothecin via intratumoral implantation Eur J Pharm Biopharm 2012 82 3 545 553 22995703
  • Tsuda K Yamanaka K Linan W Intratumoral injection of Propionibacterium acnes suppresses malignant melanoma by enhancing Th1 immune responses PLoS One 2011 6 12 e29020 22216160
  • Oh SM Oh K Lee DS Intratumoral administration of secondary lymphoid chemokine and unmethylated cytosine-phosphorothioate-guanine oligodeoxynucleotide synergistically inhibits tumor growth in vivo J Korean Med Sci 2011 26 10 1270 1276 22022177
  • Yang RK Kalogriopoulos NA Rakhmilevich AL Intratumoral hu14.18-IL-2 (IC) induces local and systemic antitumor effects that involve both activated T and NK cells as well as enhanced IC retention J Immunol 2012 189 5 2656 2664 22844125
  • Akeda T Yamanaka K Kitagawa H Intratumoral injection of OK-432 suppresses metastatic squamous cell carcinoma lesion inducing interferon- γ and tumor necrosis factor-α Clin Exp Dermatol 2012 37 2 193 194 21883396
  • Betting DJ Hurvitz SA Steward KK Combination of cyclophosphamide, rituximab, and intratumoral CpG oligodeoxynucleotide successfully eradicates established B cell lymphoma J Immunother 2012 35 7 534 543 22892450
  • Zhong H Han B Tourkova IL Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth Clin Cancer Res 2007 13 18 Pt 1 5455 5462 17875775
  • Son CH Shin DY Kim SD Improvement of antitumor effect of intratumoral injection of immature dendritic cells into irradiated tumor by cyclophosphamide in mouse colon cancer model J Immunother 2012 35 8 607 614 22996366
  • Galili U Conversion of tumors into autologous vaccines by intratumoral injection of alpha-Gal glycolipids that induce anti-Gal/alpha-Gal epitope interaction Clin Dev Immunol 2011 2011 134020 22162709
  • Hamalukic M Huelsenbeck J Schad A Wirtz S Kaina B Fritz G Rac1-regulated endothelial radiation response stimulates extravasation and metastasis that can be blocked by HMG-CoA reductase inhibitors PLoS One 2011 6 10 e26413 22039482
  • Raut CP Boucher Y Duda DG Effects of sorafenib on intra-tumoral interstitial fluid pressure and circulating biomarkers in patients with refractory sarcomas (NCI protocol 6948) PLoS One 2012 7 2 e26331 22347360
  • Alitalo K Tammela T Petrova TV Lymphangiogenesis in development and human disease Nature 2005 438 7070 946 953 16355212
  • Fan Y Du W He B The reduction of tumor interstitial fluid pressure by liposomal imatinib and its effect on combination therapy with liposomal doxorubicin Biomaterials 2013 34 9 2277 2288 23290525
  • Shayan R Achen MG Stacker SA Lymphatic vessels in cancer metastasis: bridging the gaps Carcinogenesis 2006 27 9 1729 1738 16597644
  • Oliver G Harvey N A stepwise model of the development of lymphatic vasculature Ann N Y Acad Sci 2002 979 159 165 discussion 188–196 12543725
  • Lardinois D Brack T Gaspert A Bronchoscopic radioisotope injection for sentinel lymph-node mapping in potentially resectable non-small-cell lung cancer Eur J Cardiothorac Surg 2003 23 5 824 827 12754040
  • Chen X Wang X Wang Y Improved tumor-targeting drug delivery and therapeutic efficacy by cationic liposome modified with truncated bFGF peptide J Control Release 2010 145 1 17 25 20307599